Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.

The Journal of Infectious Diseases
J P UtzS Shadomy

Abstract

In a prospective study from May 1971 to November 1973, 20 consecutive patients with a diagnosis of disseminated cryptococcosis were treated for six weeks with a combination of amphotericin B (20 mg daily) intravenously and flucytosine (150 mg/kg daily) orally. Fifteen patients has culturally docummented Cryptococcus neoformans meningitis, and three died of infection early in therapy. Of the remaining 12 patients, eight were alive and well eight to 34 months after therapy, and four died of other causes. None of the surviving patients has relapsed. Hematologic complications developed in nine patients, three of whom had no underlying lymphoreticular disorder or therapy with known cytotoxic agents. Renal insufficiency of mild degree occurred in only six patients. A shorter period of hospitalization and reduction in toxicity of amphotericin B suggest that combined therapy is a safe and efficacious alternative to other regimens.

Citations

Mar 1, 1976·Antimicrobial Agents and Chemotherapy·C A KauffmanP T Frame
Jan 1, 1977·Antimicrobial Agents and Chemotherapy·J ArroyoG S Kobayashi
Apr 22, 1978·British Medical Journal
Feb 1, 1978·Antimicrobial Agents and Chemotherapy·J R GraybillH B Levine
Nov 1, 1978·Antimicrobial Agents and Chemotherapy·J R GraybillD J Drutz
Sep 1, 1979·Postgraduate Medical Journal·D C Speller
Apr 22, 1978·British Medical Journal·A M SaundersA H Darrell
Feb 1, 1977·Antimicrobial Agents and Chemotherapy·C A Kauffman, P T Frame
Jan 1, 1986·Antimicrobial Agents and Chemotherapy·B E HarrisR B Diasio
Aug 1, 1985·Postgraduate Medical Journal·R BanksC Mackenzie
Feb 1, 1985·Annals of the Rheumatic Diseases·C BrandD Barraclough
Jan 1, 1981·Antimicrobial Agents and Chemotherapy·N K Fujita, J E Edwards
Jan 1, 1982·Annals of Surgery·N L TilneyT B Strom
Mar 8, 1980·British Medical Journal
Feb 1, 1982·Journal of the Neurological Sciences·C N De WyttG W Holt
Dec 1, 1987·Mayo Clinic Proceedings·C L Terrell, P E Hermans
Nov 1, 1981·The American Journal of Medicine·C H GinsburgJ S Trier
Mar 1, 1980·The Journal of Infection·J C MeloM J Raff
Oct 13, 1999·Neurologic Clinics·B P Kearney, F T Aweeka
Mar 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Maki HasegawaYuichi Sugiyama
Oct 21, 2011·Pharmaceutical Research·Ken-ichi Umehara, Gian Camenisch
Dec 27, 1979·The New England Journal of Medicine·J Hoffer
Dec 1, 1988·Acta Orthopaedica Scandinavica·S GovenderK Cooper
Sep 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·T L TjiaC B Tan
Jan 1, 1980·Scandinavian Journal of Infectious Diseases·H SchønheyderA Stenderup
May 1, 1981·Annals of Neurology·W E Bell
Feb 1, 1982·Clinical Pediatrics·M R HammerschlagD Papayanopulos
Feb 1, 1980·Mykosen·H SchønheyderV Esmann
Jul 1, 1993·Mycoses·G Cauwenbergh
May 1, 1992·European Journal of Epidemiology·K Iwata
Jan 17, 1980·The New England Journal of Medicine·G Medoff, G S Kobayashi
Mar 21, 2002·Fundamental & Clinical Pharmacology·András VermesJacob Dankert
Jun 9, 2016·Virulence·Michaela SpitzerGerard D Wright
May 14, 1979·Virchows Archiv. A, Pathological Anatomy and Histology·S A HardingM A Sande
Oct 1, 1996·Australian Veterinary Journal·R MalikD N Love
Feb 1, 1981·Annals of Neurology·R H BrittJ S Remington
Oct 5, 2007·Expert Review of Anti-infective Therapy·Brahm H Segal, William J Steinbach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.